Tele-Medicine in an Advanced Prostate Cancer Clinic


About this study

The purpose of this study is to describe the use of tele-medicine during the COVID-19 pandemic in our advance prostate cancer practice and evaluate patient satisfaction.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Any patient with advanced prostate cancer presented to us through Tele-consult during COVID-19 for a consult.
  • Patients consented to be enrolled in the study

Exclusion Criteria: 

  • Patients that refuse to be enrolled in the study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eugene Kwon, M.D.

Closed for enrollment

Contact information:

Vidhu Joshi CCRP

(507) 538-5772

More information


Publications are currently not available

Mayo Clinic Footer